Home

Beta Drugs Ltd Dividend

Image

Beta Drugs Ltd

NSE: BETA

Dividend Payout (-)

-

Ex-Dividend Date: NA

Key Highlights

  • The Latest Trading Price of Beta Drugs Ltd is ₹ 2198 as of 06 Dec 15:30 .

swot
swot

Monitoring Beta Drugs Ltd share price can help you stay informed about potential market shifts and opportunities.

Dividend Payout Over Time

No data available

Overview of Dividend

  • <h2><strong>Types of Dividend</strong></h2><br> <h3>Special Dividend</h3> <p>A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.</p> <br> <h3>Preferred Dividend</h3> <p>A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.</p> <br> <h3>Interim Dividend</h3> <p>Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.</p> <br> <h3>Final Dividend</h3> <p>A final dividend is issued after the year's accounts have been compiled.
  • Aside from this, the following list highlights the most prevalent sorts of dividends:</p> <br>.

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


Dividend Yield Comparison With Top Peers

* All values are in %

Image

Beta Drugs Ltd

NSE: BETA

Share Price

₹ 2198.1

-44.70 (-1.99%)

stock direction

Last updated on: Dec 06, 2024

Company Fundamentals for Beta Drugs Ltd

No data available

Dividend Payout Over Time

No data available

Net Profit Vs Dividend Per Share

SWOT Analysis Of Beta Drugs Ltd

Strength

3

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Beta Drugs Ltd

Historical Market Cap of Beta Drugs Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Beta Drugs Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Beta Drugs Ltd News Hub

Beta Drugs schedules EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 21

Read more

28 Nov 2024 15:41

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 6 November 2024 Powered b

Read more

04 Nov 2024 14:01

Beta Drugs to conduct EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 12

Read more

21 Oct 2024 13:59

Beta Drugs schedules AGM

Beta Drugs announced that the 19th Annual General Meeting (AGM) of the company will be held on 30 Se

Read more

02 Sep 2024 17:17

Beta Drugs to discuss results

Beta Drugs will hold a meeting of the Board of Directors of the Company on 14 May 2024 Powered by Ca

Read more

07 May 2024 12:58

Beta Drugs to table results

Beta Drugs will hold a meeting of the Board of Directors of the Company on 7 November 2023. Powered

Read more

01 Nov 2023 16:05

About Beta Drugs Ltd

  • Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
  • Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
  • Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
  • The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
  • The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions